Last reviewed · How we verify
NCT04717856
Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA
NA trial testing screening: HCV RNA test and risk factors questionaire in Drug Use in 300 participants. Status unknown.
21 October 2021
Quick facts
| Lead sponsor | Hasselt University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 300 |
| Start date | 21 October 2020 |
| Primary completion | 21 October 2021 |
| Estimated completion | 21 October 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- screening: HCV RNA test and risk factors questionaire
Conditions studied
- Drug Use — all drugs for Drug Use →
- Hepatitis C — all drugs for Hepatitis C →
Sponsor
Hasselt University
Who can join
18 and older, any sex, with Drug Use or Hepatitis C. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The results of the GX device are equivalent to standard venous blood sampling. With this study we are going to determine the prevalence in drug users with difficult venous access. On the other hand, we want to look at the place this device can have in primary care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04717856
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Drug Use
Currently open trials in the same condition.
- NCT07326748 — Lakota Family Acceptance Project · NA · recruiting
- NCT05776316 — Harm Reduction Services · NA · recruiting
- NCT06498167 — Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) · recruiting
- NCT05380765 — Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents · NA · recruiting
- NCT06405490 — NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC · Phase 2 · recruiting
Other Hasselt University trials
Trials by the same sponsor.
- NCT07419100 — Sedentary Behaviour, Physical Activity Patterns, and Cardiometabolic Health · NA · not yet recruiting
- NCT07505355 — Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis · recruiting
- NCT07081893 — How do Patients, Relatives and Healthcare Professionals View Person-centered Rehabilitation. · not yet recruiting
- NCT06785909 — Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain. · NA · recruiting
- NCT07175792 — Accuracy of Motor Performance Perception in Multiple Sclerosis · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04717856 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hasselt University
- Last refreshed: 22 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04717856.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing